MedTrace Logo

Validation of OxyVu for Assessing Level of Amputation With Comparison to Other Modalities

NCT00767923 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2009-06-04

No results posted yet for this study

Summary

Correlation of(OxyVu) values to to ABI, TBP, and TCOM in patients scheduled for foot level amputation because of critical limb ischemia, infection, or tissue necrosis.

Conditions

  • Critical Limb Ischemia

Sponsors & Collaborators

  • Carl T. Hayden VA Medical Center

    collaborator FED

  • HyperMed

    lead INDUSTRY

Principal Investigators

  • Robert G Frykberg, DPM MPH · Carl T. Hayden VA Medical Center

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2009-02-28
Completion
2010-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00767923 on ClinicalTrials.gov